Education
About Us
Working with TipRanks
Follow Us
Karen Dawes Insider Profile
25 Followers
Karen Dawes, Director at Repligen, holds 91.82K shares in Repligen (Ticker: RGEN), holds 1.70K shares in Barinthus Biotherapeutics (Ticker: BRNS), holds 84.59K shares in Assertio Therapeutics (Ticker: ASRT). Most recently, Karen Dawes Sold ― shares of Repligen on Dec 18, 2025 for an estimated value of $44.27K.
Profitable Transactions
8 out of 14 Profitable Transactions
Average Return
-9.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Karen Dawes holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 04, 2018 - Dec 04, 2019
Return:+84.60%
The most profitable trade made by Karen Dawes
Karen Dawes's Trading History
Repligen
Dec 18, 2025
Director
Informative Sell
44.27K
$15.28M
Barinthus Biotherapeutics
May 06, 2021
Director
Informative Buy
28.90K
$1.21K
Assertio Therapeutics
May 11, 2020
Director
Uninformative Sell
12.51K
$55.83K
PDL BioPharma
―
―
―
$5.56K
List of latest transactions for each holding click on a transaction to see Karen Dawes's performance on stock
You May Also Like
Karen Dawes insider profile FAQ
What is the percentage of profitable transactions made by Karen Dawes?
The percentage of profitable transactions made by Karen Dawes is 57%.
What is the average return per transaction made by Karen Dawes?
The average return per transaction made by Karen Dawes is -9.40%.
What stocks does Karen Dawes hold?
Karen Dawes holds: RGEN, BRNS, ASRT, PDLI stocks.
What was Karen Dawes’s latest transaction?
Karen Dawes latest transaction was an Informative Sell of $44.27K.
What was Karen Dawes's most profitable transaction?
Karen Dawes’s most profitable transaction was an Informative Sell of ASRT stock on December 4, 2018. The return on the trade was 84.60%.
What is Karen Dawes's role in Repligen?
Karen Dawes's role in Repligen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.